Evidence map›Paper›PMID 38085571›Full record

ArticleNeuro-oncology2024

Visualizing cancer-originating acetate uptake through monocarboxylate transporter 1 in reactive astrocytes in the glioblastoma tumor microenvironment.

Dongwoo Kim, Hae Young Ko, Jee-In Chung, Yongmin Mason Park, Sangwon Lee, Seon Yoo Kim, Jisu Kim, Joong-Hyun Chun, Kyung-Seok Han, Misu Lee and 20 more

Open access · greenAbstract read
In one paragraph

Article in Neuro-oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Reactive Astrocytes in Glioma: Emerging Opportunities and Challenges.International journal of molecular sciences · 2025
    Review
  6. Review
  7. Recent Update on PET/CT Radiotracers for Imaging Cerebral Glioma.Nuclear medicine and molecular imaging · 2024
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 8 institutions in 1 country.

Dongwoo KimDepartment of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.ORCID 0000-0002-1723-604X
Hae Young KoDepartment of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Jee-In ChungDepartment of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Yongmin Mason ParkCenter for Cognition and Sociality, Institute for Basic Science, Daejeon, Republic of Korea.
Sangwon LeeDepartment of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Seon Yoo KimDepartment of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Jisu KimDepartment of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Joong-Hyun ChunDepartment of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Kyung-Seok HanDepartment of Biological Sciences, Chungnam National University, Daejeon, Republic of Korea.
Misu LeeDivision of Life Science, College of Life Science and Bioengineering, Incheon National University, Incheon, Republic of Korea.
Yeon Ha JuCenter for Cognition and Sociality, Institute for Basic Science, Daejeon, Republic of Korea.
Sun Jun ParkBrain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.
Ki Duk ParkBrain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.
Min-Ho NamBrain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.ORCID 0000-0002-6191-1268
Se Hoon KimDepartment of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.ORCID 0000-0001-7516-7372
Jin-Kyoung ShimDepartment of Neurosurgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Youngjoo ParkYonsei University College of Medicine, Seoul, Republic of Korea.
Hyunkeong LimDepartment of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Jaekyung ParkDepartment of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Gwan-Ho LeeResearch Resources Division, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.
Hyunjin KimBrain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.
Suhyun KimK-Laboratory, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.
Uiyeol ParkK-Laboratory, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.
Hoon RyuK-Laboratory, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.
So Yun LeeNatural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
Sunghyouk ParkNatural Products Research Institute, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.ORCID 0000-0003-1981-3274
Seok-Gu KangDepartment of Neurosurgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Jong Hee ChangDepartment of Neurosurgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
C Justin LeeIBS School, University of Science and Technology, Daejeon, Republic of Korea.ORCID 0000-0002-3555-0980
Mijin YunDepartment of Nuclear Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.ORCID 0000-0002-1712-163X
Yonsei University · KRKorea Institute of Brain Science · KRSeoul National University · KRChungnam National University · KRIncheon National University · KRKorea Institute of Science and Technology · KRKorea University of Science and Technology · KRKyung Hee University · KR

Funding

Ministry of Science NRF-2020R1A2B5B01098109National Research Foundatio NRF-2021R1C1C2011016
6 · The paper itself

Abstract

backgroundReactive astrogliosis is a hallmark of various brain pathologies, including neurodegenerative diseases and glioblastomas. However, the specific intermediate metabolites contributing to reactive astrogliosis remain unknown. This study investigated how glioblastomas induce reactive astrogliosis in the neighboring microenvironment and explore 11C-acetate PET as an imaging technique for detecting reactive astrogliosis.

methodsThrough in vitro, mouse models, and human tissue experiments, we examined the association between elevated 11C-acetate uptake and reactive astrogliosis in gliomas. We explored acetate from glioblastoma cells, which triggers reactive astrogliosis in neighboring astrocytes by upregulating MAO-B and monocarboxylate transporter 1 (MCT1) expression. We evaluated the presence of cancer stem cells in the reactive astrogliosis region of glioblastomas and assessed the correlation between the volume of 11C-acetate uptake beyond MRI and prognosis.

resultsElevated 11C-acetate uptake is associated with reactive astrogliosis and astrocytic MCT1 in the periphery of glioblastomas in human tissues and mouse models. Glioblastoma cells exhibit increased acetate production as a result of glucose metabolism, with subsequent secretion of acetate. Acetate derived from glioblastoma cells induces reactive astrogliosis in neighboring astrocytes by increasing the expression of MAO-B and MCT1. We found cancer stem cells within the reactive astrogliosis at the tumor periphery. Consequently, a larger volume of 11C-acetate uptake beyond contrast-enhanced MRI was associated with a worse prognosis.

conclusionsOur results highlight the role of acetate derived from glioblastoma cells in inducing reactive astrogliosis and underscore the potential value of 11C-acetate PET as an imaging technique for detecting reactive astrogliosis, offering important implications for the diagnosis and treatment of glioblastomas.

Indexed as

AcetatesAstrocytesBrain NeoplasmsGlioblastomaMonocarboxylic Acid TransportersPositron-Emission TomographySymportersTumor MicroenvironmentAnimalsGliosisHumansMaleMiceMonocarboxylate Transport Protein 1PrognosisAcetatesMonocarboxylate Transport Protein 1Monocarboxylic Acid TransportersSymportersacetateglioblastomamonocarboxylate transporter 1PET imagingreactive astrogliosis

Identifiers

PMID38085571
PMCPMC11066945
OpenAlexW4389611445

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.